Overview

DNase Treatment for Dry Eyes

Status:
Terminated

Trial end date:
2017-10-11

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the tolerability and preliminary efficacy of DNase eye drops in patients with Sjogren's and Non-Sjogren Dry Eye Disease.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

University of Illinois at Chicago

Collaborators:

Genentech, Inc.
Research to Prevent Blindness

Treatments:

Ophthalmic Solutions
Tetrahydrozoline